Accessibility Menu
Bruker logo

Bruker(NASDAQ) BRKR

Current Price$59.69
Market Cap$9.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+174%
5 Year-26%
1 Year+55%
1 Month+6%
Bruker last closing stock price
MetricPriceDate
Last closeUSD 59.742026-07-22
Bruker stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.84%USD 58.662026-07-15
1 month+5.68%USD 56.532026-06-22
3 month+65.08%USD 36.192026-04-23
Year to date+27.11%USD 47.002025-12-31
1 year+54.73%USD 38.612025-07-22
3 year-19.8%USD 74.492023-07-21
5 year-26.19%USD 80.942021-07-23
Since inception+173.53%USD 22.092000-08-04

Bruker Financials at a Glance

Market Cap

$9.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.46B

Net Income (TTM)

-$11.60M

EPS (TTM)

-$0.24

P/E Ratio

-248.50

Dividend

$0.20

Beta (Volatility)

1.14 (Average)

Price

$59.69

Volume

0.875

Open

$59.46

Previous Close

$59.74

Daily Range

$58.94 - $60.74

52-Week Range

$28.53 - $64.54

Estimated Earnings Date

Aug 4, 2026

BRKR News

SellAlert-Green.png

Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide

Jonathan PoncianoDec 26, 2025
Person in a lab gazing into a microscope

Why Bruker Stock Slumped Monday

Eric VolkmanNov 4, 2025
lab test tubes and pipette.jpg

Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake

Jonathan PoncianoNov 4, 2025
Person in a lab gazing into a microscope

Why Bruker Stock Tumbled by Almost 12% Wednesday

Eric VolkmanSep 4, 2025
Foolcom-Featured.png

Bruker (BRKR) Q2 Revenue Slips 0.4%

Motley Fool Markets TeamAug 4, 2025
GettyImages-598131196

Will Bruker’s Stock Keep Climbing?

David HaenJan 16, 2020
GettyImages-1138911813

Why Bruker Jumped 12.6% Today

Todd CampbellMay 3, 2019
lab scientists GettyImages-470913492

Why Bruker Corp. Is Crashing 12% Today

Todd CampbellAug 3, 2016
Page 1

BRKR: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bruker

Bruker makes high-tech tools that help scientists study very small things like molecules and cells. These machines help experts develop new medicines and test the safety of food and materials. Hospitals and laboratories use these systems to identify germs and understand complex diseases.

The Science Tool Kit

  • BioSpin: Provides magnetic resonance tools used to determine the structure of chemical and biological samples for research and industrial applications.
  • CALID: Offers mass spectrometry and molecular spectroscopy systems for chemical analysis, food safety testing, and identifying infections in clinical labs.
  • NANO: Manufactures specialized X-ray and microscopy instruments that allow researchers to view surfaces and materials at the atomic level.
  • BEST: Produces superconducting materials and advanced tools for medical imaging, fusion research, and high-energy physics.

Expanding the Research Reach

  • Completed the acquisition of Recipe Chemicals + Instruments GmbH in 2025 to add clinical diagnostic kits for laboratory testing systems.
  • Acquired AST Revolution, LLC in 2025 to enhance its offerings in rapid testing for antibiotic resistance.
  • Purchased NanoString platforms in 2025 to expand capabilities in spatial transcriptomics, which maps how genes function within tissues.
  • Launched the MOVE-T solution for the dairy market and the VERTEX NEO R spectrometer for advanced research in 2025.

Where Precision Meets Scale

The company maintains a global footprint with major manufacturing centers in North America and Europe supported by a workforce of 11,396 employees. Its research and development investment historically exceeds the industry average to maintain technical advantages in core technology platforms.

Bruker by the Numbers

  • Revenue reached $977 million in Q4 2025, a slight decrease of 0.2% from Q4 2024.
  • Operating income rose to $76.3 million in Q4 2025, up 5.8% compared to $72.1 million in Q4 2024.
  • Net income grew to $26 million in Q4 2025, an increase of 89.8% from $13.7 million in Q4 2024.
  • Free cash flow hit $207 million in Q4 2025, representing a 35.2% increase over Q4 2024.
  • Total backlog increased to $2.57 billion as of December 31, 2025, up from $2.09 billion at the end of 2024.

The Bottom Line

Bruker has transitioned from a specialized instrument maker into a provider of comprehensive diagnostic and life science solutions. Its focus on high-end technology and strategic acquisitions helps it navigate complex markets in medicine and materials research.

AI Generated • Apr 23, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

11,085

CEO

Frank H. Laukien, PhD

Website

www.bruker.com

Headquarters

Billerica, MA 01821, US

BRKR Financials

Key Financial Metrics (TTM)

Gross Margin

45.56%

Operating Margin

5.89%

Net Income Margin

-0.34%

Return on Equity

-0.51%

Return on Capital

5.25%

Return on Assets

-0.19%

Earnings Yield

-0.40%

Dividend Yield

0.33%

Payout Ratio

-3.78%

Stock Overview

Market Cap

$9.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

152.23M

Volume

0.875

Avg. Volume

2.48M

Financials (TTM)

Gross Profit

$1.58B

Operating Income

$203.70M

EBITDA

$302.70M

Operating Cash Flow

$140.30M

Capital Expenditure

-$89.00M

Free Cash Flow

$51.30M

Cash & ST Invst.

$133.40M

Total Debt

$1.67B

Bruker Performance Analysis

Bruker annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,530,700,0004.7%
20232023-12-31USD 2,964,500,00017.1%
20242024-12-31USD 3,366,400,00013.6%
20252025-12-31USD 3,436,500,0002.1%
Bruker sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-0.5%
Q32025-09-307.9%
Q42025-12-3113.6%
Q12026-03-31-15.7%
Bruker annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.999.5%
20232023-12-31USD 2.9046.2%
20242024-12-31USD 0.76-73.9%
20252025-12-31USD -0.15N/A
Bruker sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-54.5%
Q32025-09-30-920.0%
Q42025-12-31123.9%
Q12026-03-31-76.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$823.40M

+2.7%

Gross Profit

$389.30M

-0.5%

Gross Margin

47.28%

N/A

Market Cap

$9.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$820.39K

N/A

Employees

11,085

N/A

Net Income

$14.40M

-17.2%

EBITDA

$88.70M

+0.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$133.40M

-27.6%

Total Debt

$1.67B

-20.9%

Accounts Receivable

$750.40M

+7.0%

Inventory

$1.12B

+0.4%

Long Term Debt

$1.66B

-19.9%

Short Term Debt

$8.40M

-77.7%

Return on Assets

-0.19%

N/A

Return on Invested Capital

4.27%

N/A

Free Cash Flow

$47.00M

+20.5%

Operating Cash Flow

$71.20M

+9.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GKOSGlaukos Corporation
$152.86-0.15%
KRYSKrystal Biotech, Inc.
$336.80-0.67%
TGTXTG Therapeutics, Inc.
$52.68-2.35%
CHEChemed Corporation
$503.52-0.12%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$212.25+0.02%
NOKNokia
$10.30-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.96-0.02%
TAT&T
$23.04+0.03%

Questions About BRKR

What is the current price of Bruker?

Bruker is trading at $59.74 per share.

What is the 52-week range for Bruker?

Over the past 52 weeks, Bruker has traded between $28.53 and $64.54.

How much debt does Bruker have?

As of the most recent reporting period, Bruker reported total debt of $1.67B.

How much cash does Bruker have on hand?

Bruker reported $133.40M in cash and cash equivalents in its most recent financial results.

What is Bruker’s dividend yield?

Bruker currently has a dividend yield of 0.33%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services